In summary, we report that immature/active MMP9 and total Aβ concentrations across the lifecourse in control subjects and in a subset of AMD patients showed variable levels, which were unrelated to increasing age or retinopathy. This evidence concerns the gene MMP9 and age-related macular degeneration.